When:
Time: May 27, 2021 03:00 PM Amsterdam, Berlin, Rome, Stockholm, Vienna
How to participate:
Join Zoom Meeting
No registration required.
Program:
Spring Scientific TBnet Meeting 2021
May 27
15:00h / 18:00h (CEST)
15:00 Welcome and Introduction
Frank van Leth
15:10 Future studies and applications. Chaired by Berit Lange
Pragmatic trial of high-dose rifampicin.
Martin Boeree / Jessica Aguilar
Linezolid toxicity in M/XDR-TB treatment – implication of microbiota metabolites.
Olena Rzhepishevska / Lina Davies Forsman
A comparative analysis of the severity of the pulmonary TB cases, before and during the COVID-19 pandemic.
Panciu Traian Constantin / Dragos Baiceanu
Xpert MTB/RIF false positive results in patients with TB: risk factors and impact on clinical outcome.
Irina Kontsevaya
16:30 Break
16:45 Ongoing studies. Chaired by Ilaria Motta
Performance of a new generation IGRA in immunocompromised individuals.
Martina Sester
Migrant-sensitive care and tuberculosis treatment outcome and completion.
Berit Lange
Safety and effectiveness of concomitant administration of MDR-TB and HCV treatment.
Lorenzo Guglielmetti
Cost of TB drugs and the availability of drug susceptibility testing for new TB drugs.
Gunar Günther
17:30 Keynote Lecture. Chaired by Lorenzo Guglielmetti
Four-month regimen non-inferiority study (Study 31)
Payam Nahid
17:50 Closing remarks
Frank van Leth
18:00 End of the meeting
We are looking forward to the Spring Research Meeting and hope to see many of you there!
Comments